Scrambled control peptide for use with TCS 183.
Active Analog also available.
(Modifications: Arg-13 = C-terminal amide)
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 1 mg/ml in water|
References are publications that support the biological activity of the product.
If you know of a relevant reference for TCS 184, please let us know.
View Related Products by Target
Keywords: TCS 184, TCS 184 supplier, Scrambled, control, peptide, TCS, 183, GSK3, Glycogen, Synthase, Kinase, 3, Kinases, Carbohydrate, Metabolism, TCS184, 2320, Tocris Bioscience
Citations for TCS 184
Citations are publications that use Tocris products.
Currently there are no citations for TCS 184. Do you know of a great paper that uses TCS 184 from Tocris? Please let us know.
Reviews for TCS 184
There are currently no reviews for this product. Be the first to review TCS 184 and earn rewards!
Have you used TCS 184?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.